Pediatric Hodgkin Consortium Trial Updates: Response-based omission of radiotherapy (RT) for the majority of young people with Hodgkin lymphoma (HL) while maintaining excellent outcomes: Five-year results of HOD08 for low-risk (LR) HL and initial results of cHOD17 high-risk (HR) stratum
Year: 2025
Type: conference-paper
Study design: Clinical Trial
Source: Klinische Pädiatrie
Institutions: Harvard University, Dana-Farber Cancer Institute, University of Rochester Medicine, University of Rochester, Stanford University, St. Jude Children's Research Hospital, Massachusetts General Hospital, Brigham and Women's Hospital, Boston Children's Hospital, Peoria campus of the University of Illinois System
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416930965